Work

Iatrogenic Cushing Syndrome from Topical Corticosteroid Use in an Infant: A Case Report

Year: 2026
Type: article
Abstract: Background: Topical corticosteroids are widely used in infants, but thin, highly permeable skin and a highsurface-area-to-weight ratio permit systemic absorption sufficient to cause iatrogenic Cushing syndrome.Objective: To review published cases and case series of iatrogenic Cushing syndrome and hypothalamic-pituitary-adrenal (HPA)axis suppression from topical corticosteroid use in infants.Methods: Narrative review of case reports, case series, cohort and meta-analytic data, and management literature.Findings: Most reported infant cases followed unsupervised use of superpotent agents, chiefly clobetasol propionate, applied tothe diaper area for 1-7 months; biochemistry uniformly showed secondary adrenal insufficiency (low cortisol with low orinappropriately normal ACTH). A meta-analysis of 522 children found suppression rising from 2.0% with low-potency to 6.6%with high-potency agents. Recovery after physiological hydrocortisone replacement and gradual withdrawal took a median of 2-6months across series.Conclusions: Clinicians should recognise cushingoid infants promptly, avoid abrupt cessation of potent topical steroids, andtaper under hydrocortisone cover to prevent adrenal crisis.
Language: English
Field: Medicine
Open Access status: hybrid
OpenAlex ID: W7208816457
FWCI:
Cites:
Cited by:
Related to: 10